Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Detectiome
Dubai, Dubai, UAE
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Detectiome has launched Revonco as a research-use-only product. It leverages generative AI and multiomic analysis to detect multiple cancers at their earliest stages. Clinical validation and regulatory registration are pending; no published clinical results yet.
- Therapeutic areas
- Oncology
- Modalities
- Multiomics liquid biopsy (genomics, epigenomics, transcriptomics)AI-powered diagnostics
- Industry
- Molecular Diagnostics
02
Partnerships
TECOM Group’s in5 incubatorDubai Science Park
Beyond the preview
Go deeper on Detectiome.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Detectiome.